company background image
506943

J. B. Chemicals & Pharmaceuticals BSE:506943 Stock Report

Last Price

₹2.04k

Market Cap

₹157.7b

7D

1.0%

1Y

26.3%

Updated

08 Dec, 2022

Data

Company Financials +
506943 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance1/6
Financial Health5/6
Dividends3/6

506943 Stock Overview

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally.

J. B. Chemicals & Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for J. B. Chemicals & Pharmaceuticals
Historical stock prices
Current Share Price₹2,038.70
52 Week High₹2,149.90
52 Week Low₹1,339.05
Beta-0.11
1 Month Change2.33%
3 Month Change10.47%
1 Year Change26.29%
3 Year Change391.79%
5 Year Change589.33%
Change since IPO39,953.05%

Recent News & Updates

Recent updates

Shareholder Returns

506943IN PharmaceuticalsIN Market
7D1.0%-1.5%-0.05%
1Y26.3%-3.9%5.2%

Return vs Industry: 506943 exceeded the Indian Pharmaceuticals industry which returned -3.9% over the past year.

Return vs Market: 506943 exceeded the Indian Market which returned 5.2% over the past year.

Price Volatility

Is 506943's price volatile compared to industry and market?
506943 volatility
506943 Average Weekly Movement3.9%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement5.5%
10% most volatile stocks in IN Market8.9%
10% least volatile stocks in IN Market3.5%

Stable Share Price: 506943 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 506943's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19764,340Nikhil Choprahttps://www.jbpharma.com

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms.

J. B. Chemicals & Pharmaceuticals Limited Fundamentals Summary

How do J. B. Chemicals & Pharmaceuticals's earnings and revenue compare to its market cap?
506943 fundamental statistics
Market Cap₹157.70b
Earnings (TTM)₹3.85b
Revenue (TTM)₹28.19b

41.0x

P/E Ratio

5.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
506943 income statement (TTM)
Revenue₹28.19b
Cost of Revenue₹10.36b
Gross Profit₹17.84b
Other Expenses₹13.99b
Earnings₹3.85b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)49.75
Gross Margin63.27%
Net Profit Margin13.65%
Debt/Equity Ratio15.1%

How did 506943 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

16%

Payout Ratio